Immunity

Brain-border immune cells take up amyloid on a daily cycle in mice

Experiments found greater uptake during the rest phase, while deleting a clock gene in these cells worsened amyloid deposits in an Alzheimer’s mouse model.

Graphical abstract from Immunity
Open the figure at full size
Graphical abstract. Barr et al., CC BY

Our read

Mechanisms
Studied:
Experiments in mice
What changed:
Brain-border immune cells took up more amyloid-beta during the rest phase of the daily cycle
The catch:
Clock-gene deletion was the sole model of disrupted daily rhythms in the amyloid-buildup experiment
Stake:
An author holds shares in Annexon Bioscience.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Mice were studied in experiments that measured gene activity in individual brain immune cells across the day-night cycle. Immune cells called brain border-associated macrophages showed strong daily rhythms. During the rest phase, these cells increased their machinery for taking in material and absorbed more fluid-borne substances, including amyloid-beta, a protein fragment that can form plaques.

Bmal1, a gene involved in the body’s daily clock, regulated this rhythm. CD206, a cell-surface protein that helps capture material, mediated uptake. The uptake rhythm was disrupted with age. In an Alzheimer’s disease mouse model, deleting Bmal1 in these cells worsened amyloid plaque buildup around blood vessels and in the membranes covering the brain.

Why it matters

The authors suggest that disturbed timing of brain-border immunity may be one route linking disrupted daily rhythms to the amyloid buildup associated with Alzheimer’s disease.

Caveats

Deleting a clock gene in a mouse Alzheimer’s model leaves open whether other disruptions of daily rhythms have the same effect on amyloid buildup.

Comments

Be the first to comment.